These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7245516)

  • 21. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
    de Koning EJ; Fleming KA; Gray DW; Clark A
    J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary calcification in chronic dialysis patients.
    Jarava C; Martí V; Gurpegui ML; Merello JI; Rdez-Quesada B; Palma A
    Nephrol Dial Transplant; 1993; 8(7):673-4. PubMed ID: 8396756
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of parathormone on arterial blood pressure in patients on hemodialysis].
    Kostić S; Veljković S; Cekić S; Nesić M; Cukuranović R; Koradjević G; Radenković S; Velicković D; Raicević R; Radenković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():115-6. PubMed ID: 9102868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reoperation for renal hyperparathyroidism.
    Hibi Y; Tominaga Y; Sato T; Katayama A; Haba T; Uchida K; Ichimori T; Numano M; Tanaka Y; Takagi H; Imai T; Funahashi H; Nakao A
    World J Surg; 2002 Oct; 26(10):1301-7. PubMed ID: 12205559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
    Makdassi R; Decourcelle PH; Moriniere P; Coevoet B; de Fremont JF; Kassouf J; Roussel A; Gheerbrand JD; Andrejak M; Fournier A
    Proc Eur Dial Transplant Assoc; 1981; 18():642-7. PubMed ID: 7329992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Parathormone as a uremic toxin. Possible effect on respiratory muscle function in uremia].
    Gómez-Fernández P; Sánchez Agudo L; Calatrava JM; Martínez ME; Escuin Sancho F; Selgas R; Sánchez Sicilia L
    Med Clin (Barc); 1984 Mar; 82(9):395-7. PubMed ID: 6717152
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
    Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
    Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.
    Navarro JF; Teruel JL; Lasunción MA; Mora-Fernandez C; Ortuño J
    Clin Nephrol; 1998 May; 49(5):303-7. PubMed ID: 9617494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The isolation and assay of human parathyroid hormone.
    O'Riordan JL; Woodhead JS
    Clin Sci; 1969 Oct; 37(2):572. PubMed ID: 5359029
    [No Abstract]   [Full Text] [Related]  

  • 33. Creatine phosphokinase in long-term dialysis patients.
    Soffer O; Fellner SK; Rush RL
    Arch Intern Med; 1981 Feb; 141(2):181-8. PubMed ID: 7458513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of pancreatic disease in chronic renal failure.
    Avram MM
    Nephron; 1977; 18(1):68-71. PubMed ID: 846627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia.
    Arcidiacono MV; Cozzolino M; Brancaccio D; Gallieni M; Lesma E; Carelli S; Gorio A; Di Giulio AM
    J Nephrol; 2007; 20(2):228-33. PubMed ID: 17514628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impotence in patients with uremia: a possible role for parathyroid hormone.
    Massry SG; Goldstein DA; Procci WR; Kletzky OA
    Nephron; 1977; 19(6):305-10. PubMed ID: 927622
    [No Abstract]   [Full Text] [Related]  

  • 37. Sexual function in uremic patients. 18 months' follow-up in 26 subjects.
    Di Paolo N; Capotondo L; Gaggiotti E; Rossi P
    Contrib Nephrol; 1990; 77():34-44. PubMed ID: 2344744
    [No Abstract]   [Full Text] [Related]  

  • 38. Altered taste perception in uremia.
    Fornari AJ; Avram MM
    Trans Am Soc Artif Intern Organs; 1978; 24():385-8. PubMed ID: 716029
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence and association of depression with uremia in dialysis population: a retrospective cohort analysis.
    Liu J; Zhang F; Wang Y; Wu D
    Medicine (Baltimore); 2020 Jun; 99(24):e20401. PubMed ID: 32541461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Leptospirosis icterohaemorrhagica with severe azotemia].
    Sorensen FH; Ingemar K; Skjoldborg H
    Ugeskr Laeger; 1968 May; 130(22):934-6. PubMed ID: 5699686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.